Urine test can spot more than nine in 10 bladder cancers
Summary
A new urine test trialed by the NHS can detect over 90% of bladder cancer cases. This test may reduce the need for invasive bladder checks called cystoscopies and speed up diagnosis.Key Facts
- The urine test was studied in nearly 1,000 patients across seven hospitals in England and Scotland.
- It identified 92% of bladder cancer cases in the trial.
- A negative test result means there is more than a 99% chance the patient does not have bladder cancer.
- The test looks for over 450 DNA mutations linked to bladder cancer in 23 genes.
- Over 300,000 cystoscopies are done each year in the UK, which are invasive and cause long waiting times.
- The test was developed by the University of Birmingham with funding from Cancer Research UK (CRUK).
- A company called Nonacus has commercialized the test and shares revenue with the university and CRUK.
- Bladder cancer mostly affects men over 60, and the main symptom is blood in the urine.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
